CONMED Corporation (NASDAQ:CNMD) is set to announce third quarter earning results on Wednesday 28th October 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, CNMD to report 3Q20 income of $ 0.23 per share.
For the full year, analysts anticipate top line of $ 838.82 million, while looking forward to income of $ 1.50 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 1,010.49 million ~ $ 1,012.40 million, where as bottomline are predicted in a range of $ 3.08 ~ $ 3.13 per share
Click Here For More Historical Outlooks Of CONMED Corporation
Previous Quarter Performance
CONMED Corporation unfold loss for the second quarter of $ 0.07 per share, from the revenue of $ 157.78 million. The quarterly revenues dropped 32.36 percent compared with the same quarter last year. The consensus estimates are loss of $ 0.95 per share from $ 126.59 million in revenue. The bottom line results beat street analysts by $ 0.88 or 92.63 percent, at the same time, top line results outshined analysts by $ 31.19 million or 24.64 percent.
Stock Performance
Shares of CONMED Corporation traded low $ -2.05 or -2.47 percent on Tuesday, reaching $ 80.84 with volume of 289.90 thousand shares. CONMED Corporation has traded high as $ 83.33 and has cracked $ 80.49 on the downward trend
According to the previous trading day, closing price of $ 80.84, representing a 120.10 % increase from the 52 week low of $ 37.66 and a 29.04 % decrease over the 52 week high of $ 116.81.
The company has a market capital of $ 2.31 billion and is part of the Healthcare sector and Medical Devices industry.
Recent Stock Dividend Announcement
The board of directors has authorized quarterly dividend of $ 0.20 per share on August 13, 2020. The dividend were payable on October 5, 2020 to holders of record as of the close of business on September 15, 2020 and ex-dividend date on September 14, 2020.
Conference Call
CONMED Corporation will be hosting a conference call at 4:30 PM eastern time on 28th October 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.conmed.com
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. The company offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, plastic, ENT, neurological, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. It offers orthopedic surgery products under Hall, CONMED Linvatec, Concept, and Shutt brands.
